Differentiating between luminal A and normal-like breast cancer poses a challenge due to the positive expression of estrogen receptor (ER) and progesterone receptor (PR), negative expression of human epidermal growth factor 2 (HER2), and low levels of Ki67, a common proliferation marker for human tumor cells, in both subtypes [6]. This evidence concerns the gene ESR1 and breast cancer.